Key details
Phase
Early testing / Safety & dosing
Sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Enrollment target
~25 participants
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated January 2025